KPC PharmaceuticalsInc Balance Sheet Health
Financial Health criteria checks 6/6
KPC PharmaceuticalsInc has a total shareholder equity of CN¥5.7B and total debt of CN¥769.1M, which brings its debt-to-equity ratio to 13.5%. Its total assets and total liabilities are CN¥10.0B and CN¥4.3B respectively. KPC PharmaceuticalsInc's EBIT is CN¥500.8M making its interest coverage ratio -1915.5. It has cash and short-term investments of CN¥2.0B.
Key information
13.5%
Debt to equity ratio
CN¥769.10m
Debt
| Interest coverage ratio | -1915.5x |
| Cash | CN¥2.01b |
| Equity | CN¥5.71b |
| Total liabilities | CN¥4.31b |
| Total assets | CN¥10.02b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 600422's short term assets (CN¥7.6B) exceed its short term liabilities (CN¥4.0B).
Long Term Liabilities: 600422's short term assets (CN¥7.6B) exceed its long term liabilities (CN¥357.2M).
Debt to Equity History and Analysis
Debt Level: 600422 has more cash than its total debt.
Reducing Debt: 600422's debt to equity ratio has reduced from 17.2% to 13.5% over the past 5 years.
Debt Coverage: 600422's debt is well covered by operating cash flow (79.2%).
Interest Coverage: 600422 earns more interest than it pays, so coverage of interest payments is not a concern.